Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on products for severe and life-threatening disease states, including hematologic, kidney, and neurologic diseases; transplant rejection; cancer; and…More autoimmune disorders.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (288)
Alexion Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 288 reviews.